Chelsea have reportedly wrapped up a deal for Bayer Leverkusen forward Andre Schurrle, having agreed to terms with the German club on Wednesday (per Die Welt h/t ESPN).
Reports state that the Blues spent €22 million to bring the attacking midfielder to Stamford Bridge, with a five-year deal thought to be in motion—something Leverkusen officials should confirm on Friday when they meet in London to finalize a deal.
Raphael Honigstein @honigstein
Schürrle update, via @Tim_Roehn : Leverkusen official expected in London on Friday to conclude deal. Chelsea and AS have agreed 5y deal2013-4-16 12:43:15
I've already discussed the reported deal in much greater length here, with both Leverkusen and Schurrle to emerge as big winners from the summer transfer.
However, what I'm not completely sold on is Chelsea emerging as winners from the deal. Even if they have nabbed a very strong attacking midfielder for €22 million and will likely see great results from him on the field, it's hard to see the West London club benefiting much from the deal—purely for the fact that it will seemingly end their hopes of landing a top striker in the summer transfer window.
The Blues have had long-term interests in both Atletico Madrid striker Radamel Falcao and Napoli striker Edinson Cavani. Even Fiorentina striker Stevan Jovetic has been rumored as a possible arrival to Stamford Bridge, and while they haven't been able to nab either of the stars in the past three transfer windows, it would seem that this year they have their best chance to try and bring one of them in.
Or should I say, had their best chance to bring one of them in.
All three strikers will cost upwards of €30 million in their own right, with the likes of Falcao and Cavani likely to cost closer to €50 million over the summer.
But that's not the issue—the issue is about there being space in the team for both Chelsea and the player to deem a move worthwhile. And at the moment, given all the players currently on the books at Chelsea, there doesn't seem to be a whole lot of space.
Look at the current squad that the Blues have for next season:
|Defensive Midfielders||Attacking Midfielders||Forwards/Strikers|
John Obi Mikel
Kevin De Bruyne
Now, while all of these players won't be around in the summer (with the likes of Frank Lampard and Kevin De Bruyne already touted as potential movers), the Blues still have an incredible abundance of riches throughout their midfield and attack.
While that might seem like a selling point, there's a point at which it becomes too much, and prospective transfers will see it as a negative.
Obviously a move for Falcao or Cavani would make them the big-name striker at the club, but there's a definite case to be made that even their biggest-name players would see serious time on the sidelines next season if their squad stays like this.
Both Eden Hazard and Oscar are already looking at minutes on the sideline. Heck, Lukaku hasn't even gotten a game for Chelsea in two years despite being one of the hottest young strikers around!
Neither Cavani or Falcao could be completely convinced by the Blues that their minutes wouldn't be impacted next season. Which, when you're comparing the offers that are likely to flood in from Manchester City, Paris Saint Germain, could well see the Blues' offers come in second place.
Without a move to sell off some of their other attacking options this summer, Chelsea will struggle to land the big-name striker they've been chasing for so long. Falcao is reportedly looking elsewhere, Real Madrid are reportedly the front-runners for Cavani and Arsenal may even be sneaking ahead in the race for Jovetic this summer.
If the Blues don't want one of that trio, then it's a moot point. Schurrle is a deal that gives them some positives, and they have to work through the rest.
But if they do want to sign one of those three, then they're in trouble.
Without selling off some players themselves, it's hard to see Chelsea wrapping up a deal for either star over the upcoming summer transfer window.
Hit me up on Twitter for more sports goodness: Follow @dantalintyre